Clinical Immunology & Research
Open Access
ISSN: 2639-8494
Research Article
How Nanotherapy Fails SARS-CoV-2: The BI(G)MED Experience
Authors: Glady Gilbert, Bahi-Jaber Narges.
Abstract
While the Sars-CoV-2 epidemics seems to rebound more and more despite the massive vaccination surveys that prove not only moderately efficacy but more deleterious effects than expected, the need for an effective treatment against the coronavirus is imperatively needed. In this article we present such a treatment, based on empirical clinical observations. The goal of this treatment is to give hope to as many patients as possible for the existence of an effective and safe treatment without any side effect.
View / Download PDF
Citation:
Glady Gilbert, Bahi-Jaber Narges. How Nanotherapy Fails SARS-CoV-2: The BI(G)MED Experience. 2021; 5(2).
DOI:
10.33425/2639-8494.1041
Editor-in-Chief
Jianxun Song
Microbial Pathogenesis & Immunology | Pennsylvania State University
View full editorial board →
Journal Metrics
Impact Factor
2.4*
Acceptance Rate
74%
Time to first decision
6-10 Days
Submission to acceptance
12-15 Days